- Home
- ROIV vs FRHC Comparison
ROIV vs FRHC Comparison
Compare ROIV & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | FRHC |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 8.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | FRHC |
|---|---|---|
| Price | $21.80 | $133.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $24.31 | N/A |
| AVG Volume (30 Days) | ★ 7.9M | 69.8K |
| Earning Date | 11-10-2025 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $20,329,000.00 | ★ $1,563,510,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $376.94 | N/A |
| P/E Ratio | ★ N/A | $1,740.38 |
| Revenue Growth | N/A | ★ 16.04 |
| 52 Week Low | $8.73 | $111.85 |
| 52 Week High | $23.47 | $194.01 |
Technical Indicators
Market Signals| Indicator | ROIV | FRHC |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 42.75 |
| Support Level | $21.60 | $130.00 |
| Resistance Level | $23.47 | $135.82 |
| Average True Range (ATR) | 0.84 | 4.04 |
| MACD | 0.03 | 0.80 |
| Stochastic Oscillator | 53.85 | 37.76 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.